Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP900812.RAEFSogj4SoIOfrcxSPg5hOYtEoaDXqtJcsaMgETo6Yg4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP900812.RAEFSogj4SoIOfrcxSPg5hOYtEoaDXqtJcsaMgETo6Yg4130_assertion type Assertion NP900812.RAEFSogj4SoIOfrcxSPg5hOYtEoaDXqtJcsaMgETo6Yg4130_head.
- NP900812.RAEFSogj4SoIOfrcxSPg5hOYtEoaDXqtJcsaMgETo6Yg4130_assertion description "[In addition, the 52 single nucleotide polymorphisms associated at P<10(-4) included rs438034 (CENPF; P=4.86�10(-6)), previously correlated with cancer progression, and rs2255235 (B2M; P=3.10�10(-5)) and rs2064501 (IL22RA2; P=4.81�10(-5)) which map to B-cell genes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP900812.RAEFSogj4SoIOfrcxSPg5hOYtEoaDXqtJcsaMgETo6Yg4130_provenance.
- NP900812.RAEFSogj4SoIOfrcxSPg5hOYtEoaDXqtJcsaMgETo6Yg4130_assertion evidence source_evidence_literature NP900812.RAEFSogj4SoIOfrcxSPg5hOYtEoaDXqtJcsaMgETo6Yg4130_provenance.
- NP900812.RAEFSogj4SoIOfrcxSPg5hOYtEoaDXqtJcsaMgETo6Yg4130_assertion SIO_000772 21659360 NP900812.RAEFSogj4SoIOfrcxSPg5hOYtEoaDXqtJcsaMgETo6Yg4130_provenance.
- NP900812.RAEFSogj4SoIOfrcxSPg5hOYtEoaDXqtJcsaMgETo6Yg4130_assertion wasDerivedFrom befree-2016 NP900812.RAEFSogj4SoIOfrcxSPg5hOYtEoaDXqtJcsaMgETo6Yg4130_provenance.
- NP900812.RAEFSogj4SoIOfrcxSPg5hOYtEoaDXqtJcsaMgETo6Yg4130_assertion wasGeneratedBy ECO_0000203 NP900812.RAEFSogj4SoIOfrcxSPg5hOYtEoaDXqtJcsaMgETo6Yg4130_provenance.